Sh Fosun Pharma reported CNY1.61B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui CNY 2.78B 379.11M Sep/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Sh Pharmaceutical CNY 3.57B 803.74M Jun/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 10.59B 2.61B Sep/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M Jun/2026